NEW YORK (GenomeWeb News) – Luminex and Exiqon said today that they have signed an agreement to co-develop and commercialize microRNA products for Luminex’s xMAP platform.
 
Under the terms of the agreement, Exiqon will develop and manufacture microRNA detection chemistries on behalf of the Luminex Bioscience Group.
 
The final microRNA products will be based on Luminex's xMAP instruments and Exiqon's Locked Nucleic Acid probes, nucleotide analogs that bind to RNA and DNA targets.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.